The goal is to help ensure that prescription drug marketing information for consumers and healthcare providers is truthful and balanced. Here’s what the agency plans to research.
Diabetes drug spending is on the rise, but there are ways to control it.
Director of medication safety and quality for the American Society of Health-System Pharmacists shares how providers can better work with pharmacists to address the opioid epidemic.
More targeted therapies for autoimmune diseases are on the horizon. Here’s what to anticipate in 2018.
PBMs are in a unique position to help curb opioid abuse. Here are four programs that demonstrate promising outcomes.
The Innovation and Value Initiative's Mark Linthicum talks to Managed Healthcare Executive (MHE) a new tool to better measure value in healthcare treatments.
The Innovation and Value Initiative launched the Open-Source Value Project, creating tools that help payers, providers, and healthcare systems make informed and patient-centered decisions that produce better health outcomes.
Healthcare executives have a unique leadership role to play in addressing the opioid crisis. Here’s what you need to do now.
A poll from the Biosimilars Council, a division of the Association for Accessible Medicines, has interesting findings about placing biosimilars and branded biologics on a level playing field to save money.
Treating RA is a work in progress. Here’s what you need to know.